LASCO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 6.022
EU - Europa 4.114
AS - Asia 3.527
SA - Sud America 1.301
AF - Africa 81
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.056
Nazione #
US - Stati Uniti d'America 5.909
SG - Singapore 1.430
CN - Cina 1.179
BR - Brasile 1.125
IE - Irlanda 1.081
SE - Svezia 948
DE - Germania 538
IT - Italia 427
HK - Hong Kong 420
FI - Finlandia 245
VN - Vietnam 190
FR - Francia 170
RU - Federazione Russa 155
GB - Regno Unito 148
UA - Ucraina 135
PL - Polonia 100
IN - India 87
AR - Argentina 67
CA - Canada 61
TR - Turchia 41
EC - Ecuador 35
BE - Belgio 34
MX - Messico 32
NL - Olanda 26
BD - Bangladesh 25
IQ - Iraq 25
ES - Italia 20
PK - Pakistan 18
VE - Venezuela 18
ZA - Sudafrica 18
JP - Giappone 16
MA - Marocco 15
CZ - Repubblica Ceca 14
PY - Paraguay 14
AT - Austria 13
EG - Egitto 13
CL - Cile 12
UZ - Uzbekistan 12
ID - Indonesia 10
JO - Giordania 10
UY - Uruguay 10
CI - Costa d'Avorio 9
CO - Colombia 9
LT - Lituania 9
AZ - Azerbaigian 8
CH - Svizzera 7
KE - Kenya 7
SN - Senegal 7
AL - Albania 6
BG - Bulgaria 6
CU - Cuba 6
KR - Corea 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
IL - Israele 5
BO - Bolivia 4
DZ - Algeria 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
RO - Romania 4
TN - Tunisia 4
BH - Bahrain 3
BN - Brunei Darussalam 3
DK - Danimarca 3
EE - Estonia 3
IR - Iran 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 15.047
Città #
Dublin 1.080
Chandler 781
Ashburn 746
Dallas 686
Singapore 684
Nyköping 514
Beijing 484
Hong Kong 394
Jacksonville 371
Munich 257
Princeton 194
Dearborn 189
The Dalles 183
Medford 153
Los Angeles 148
Messina 147
Ann Arbor 145
New York 143
Cambridge 133
Bremen 124
Des Moines 117
Boardman 101
São Paulo 87
Warsaw 87
Helsinki 78
Ho Chi Minh City 70
Jinan 67
Buffalo 62
Shenyang 57
Turku 54
Tianjin 53
Nanjing 50
San Mateo 48
Wilmington 46
Hanoi 44
Redondo Beach 43
Pune 41
Lancaster 36
Woodbridge 36
Moscow 34
Brussels 33
Rio de Janeiro 33
Houston 32
Seattle 31
Belo Horizonte 30
Guangzhou 29
Frankfurt am Main 28
Hebei 28
Zhengzhou 27
Curitiba 26
Haikou 26
Hangzhou 24
Brasília 23
Düsseldorf 23
Nanchang 23
Catania 22
Brooklyn 21
Taizhou 21
Boston 19
Montreal 19
Santa Clara 19
Denver 18
Nuremberg 18
Strasbourg 18
Hyderabad 17
London 16
Ningbo 16
Fuzhou 15
Porto Alegre 15
Toronto 15
Chicago 14
Council Bluffs 14
Jiaxing 14
Johannesburg 14
Poplar 14
Quito 14
Baghdad 13
Taiyuan 13
Chennai 12
Goiânia 12
Lauterbourg 12
Orem 12
Tashkent 12
Changsha 11
Lanzhou 11
Manaus 11
San Francisco 11
Stockholm 11
Tokyo 11
Amsterdam 10
Ankara 10
Brno 10
Fremont 10
Guarulhos 10
Milan 10
Ottawa 10
Ribeirão Preto 10
Abidjan 9
Amman 9
Florianópolis 9
Totale 9.795
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 238
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 171
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 160
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 156
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 151
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 150
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 149
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 148
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 146
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 143
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 142
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 141
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 140
Hyponatremia as a leading sign of hypopituitarism 135
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 128
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 127
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 125
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 124
Frailty and lipid profile in elderly hospitalized patients 124
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 124
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 123
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 123
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 123
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 122
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 122
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 120
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 119
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 119
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 118
Anxiety levels as risk factor for osteoporosis in postmenopausal women 117
IL-22 circulating serum levels in centenarians. 116
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 115
HEMOSTATIC VARIABLES IN ARTERIAL-HYPERTENSION 114
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 113
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 112
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 112
Frailty modifications and prognostic impact in older patients admitted in acute care 111
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 110
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 109
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 106
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 106
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 106
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 105
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 105
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 104
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 104
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 103
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 103
Relationship between blood pressure and frailty in older hypertensive outpatients 103
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 103
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 102
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 102
Effects of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension 101
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 101
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 101
Valutazione e comparazione del filtrato glomerulare stimato con due differenti formule in una popolazione di centenari 100
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 100
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 100
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 100
Healthy centenarians show high levels of circulating interleukin-22 (IL-22). 99
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 99
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 99
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 99
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 99
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 98
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 98
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 98
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 98
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 98
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 97
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 97
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 97
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 97
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 96
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 96
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 96
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 95
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 95
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 95
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 94
Vitamin D status and the relationship with bone fragility fractures in HIV-infected patients: A case control study 94
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 94
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 93
DISAPPEARANCE OF A VIRILIZING ADRENAL TUMOR FOLLOWING THERAPY WITH CYPROTERONE ACETATE. 93
Sincope conseguente a severa depressione della conduzione atrio-ventricolare trattata con impianto di Pace-maker in un soggetto anziano affetto da fibrillazione atriale permanente e demenza in trattamento con rivastigmina 92
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 92
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 92
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 92
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 91
Serum anti-p53 autoantibodies in patients with type 1 diabetes 90
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 90
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 90
Electrocardiographic changes in centenarians: a study on 42 subjects and comparison with the literature 90
Serum levels of apelin-36 are decresed in elderly hospitalized patients with heart failure 90
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 90
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 89
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 88
Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia (Endocrine, (2019), 65, 3, (569-579), 10.1007/s12020-019-01908-x) 88
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 87
Effect of long-term treatment with raloxifene on mammary density in postmenopausal women 86
Totale 11.046
Categoria #
all - tutte 58.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 67 29 70 15 100 48 45
2021/20221.303 10 183 21 54 33 9 106 39 122 210 127 389
2022/20233.155 225 332 153 206 307 286 21 175 1.314 15 88 33
2023/2024811 62 135 34 107 57 189 19 58 6 27 12 105
2024/20253.519 55 58 61 213 180 111 115 675 898 230 328 595
2025/20263.742 588 845 618 693 899 99 0 0 0 0 0 0
Totale 15.381